Pharma Reaserch Prod Co Ltd (214450) — Tangible Net Worth Ratio
Pharma Reaserch Prod Co Ltd (214450) has a Tangible Net Worth Ratio of 97.4% as of December 2025. This metric is calculated by deducting intangible assets (₩18.99 Billion) from net assets (₩723.88 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See what is Pharma Reaserch Prod Co Ltd's book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Pharma Reaserch Prod Co Ltd Tangible Net Worth Ratio (2015–2025)
This chart shows how Pharma Reaserch Prod Co Ltd's Tangible Net Worth Ratio has changed across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 97.4%, reflecting net assets of ₩723.88 Billion with intangible assets of ₩18.99 Billion KRW. Also explore Pharma Reaserch Prod Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Pharma Reaserch Prod Co Ltd (2015–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Pharma Reaserch Prod Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see 214450 market cap.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.4% | ₩723.88 Billion | ₩18.99 Billion | ₩1.04 Trillion | ▲ +0.8 pp |
| 2024 | 96.6% | ₩569.44 Billion | ₩19.54 Billion | ₩855.70 Billion | ▲ +1.0 pp |
| 2023 | 95.6% | ₩462.19 Billion | ₩20.32 Billion | ₩535.28 Billion | ▲ +2.6 pp |
| 2022 | 93.0% | ₩343.50 Billion | ₩24.02 Billion | ₩478.06 Billion | ▲ +1.5 pp |
| 2021 | 91.5% | ₩305.44 Billion | ₩26.02 Billion | ₩427.65 Billion | ▲ +2.4 pp |
| 2020 | 89.1% | ₩245.42 Billion | ₩26.81 Billion | ₩319.83 Billion | ▲ +3.3 pp |
| 2019 | 85.7% | ₩209.07 Billion | ₩29.81 Billion | ₩269.93 Billion | ▲ +1.9 pp |
| 2018 | 83.8% | ₩197.62 Billion | ₩31.98 Billion | ₩258.19 Billion | ▼ -14.9 pp |
| 2017 | 98.7% | ₩178.85 Billion | ₩2.28 Billion | ₩189.03 Billion | ▲ +0.1 pp |
| 2016 | 98.7% | ₩171.64 Billion | ₩2.29 Billion | ₩179.33 Billion | ▼ -0.3 pp |
| 2015 | 98.9% | ₩156.75 Billion | ₩1.65 Billion | ₩169.31 Billion | — |